These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17288272)

  • 1. [Efficacy of intravenous immunoglobulins in bacterial infections].
    Beloborodova NV; Popov DA
    Anesteziol Reanimatol; 2006; (6):72-6. PubMed ID: 17288272
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the treatment of neonatal sepsis and meningitis.
    Weisman LE
    Isr J Med Sci; 1994; 30(5-6):455-8. PubMed ID: 8034503
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of IVIG in treatment of generalized infections].
    Lewandowicz-Uszyńska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():85-90. PubMed ID: 12661418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins in the therapy of severe bacterial infections, immunodeficiencies, and autoimmune diseases.
    Popovic M; Glisic B; Mitrovic D; Stefanovic D; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2376-7. PubMed ID: 11377565
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.
    Simoes J; Sciascia S; Camara I; Baldovino S; Karim Y; Roccatello D; Cuadrado MJ
    J Clin Rheumatol; 2015 Jan; 21(1):35-7. PubMed ID: 25539433
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection.
    Hill HR
    Pediatr Infect Dis J; 1993 Jul; 12(7):549-58; quiz 559. PubMed ID: 8345995
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment in autism.
    Plioplys AV
    J Autism Dev Disord; 2000 Feb; 30(1):73-4. PubMed ID: 10819125
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.
    Bonagura VR; Marchlewski R; Cox A; Rosenthal DW
    J Allergy Clin Immunol; 2008 Jul; 122(1):210-2. PubMed ID: 18602574
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulins and mucous membrane pemphigoid.
    Mignogna MD; Leuci S; Piscopo R; Bonovolontà G
    Ophthalmology; 2008 Apr; 115(4):752-752.e1. PubMed ID: 18387410
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child.
    Cao YH; Zhang GY; Zhang GC
    Clin Pediatr (Phila); 2009 Jul; 48(6):674-6. PubMed ID: 19286620
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.
    Valiquette L; Low DE; McGeer AJ
    Clin Infect Dis; 2009 Nov; 49(9):1377-9. PubMed ID: 19788361
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma.
    Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K
    Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.
    Burnett AM; Domachowske JB
    Clin Pediatr (Phila); 2007 Jul; 46(6):550-5. PubMed ID: 17579110
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 17. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
    Dauvilliers Y; Abril B; Mas E; Michel F; Tafti M
    Neurology; 2009 Oct; 73(16):1333-4. PubMed ID: 19841387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of intravenous immunoglobulins in central pontine myelinolysis].
    Escribano-Gascón AB; Casanova-Peño LI; Bartolomé-Puras M; Porta-Etessam J
    Neurologia; 2008; 23(6):392-4. PubMed ID: 18597194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting treatment responses to IV immunoglobulins: can we already ask the genes?
    Lehmann HC; Kieseier BC
    Neurology; 2009 Oct; 73(17):1344-5. PubMed ID: 19776375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.